Zuo‐Lin Xiang
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 15
- Bone health and treatments 4
-
- RNA modifications and cancer 4
- Co-authors
- Jia Fan (12 shared papers)Zhao‐Chong Zeng (16 shared papers)Zhao–You Tang (9 shared papers)Haiying Zeng (5 shared papers)Jian He (3 shared papers)Yun-shan Tan (4 shared papers)Dongmei Gao (1 shared paper)Hui‐Chuan Sun (3 shared papers)
- Journals
- Molecular Biology Reports (3 papers)Oncotarget (2 papers)BMC Bioinformatics (2 papers)BMC Cancer (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Zuo‐Lin Xiang
34 papers receiving 624 citations
Peers
Comparison fields: 5 of 61
- Hepatology 156
- Cancer Research 241
- Oncology 227
- Immunology 91
- Molecular Biology 285
Countries citing papers authored by Zuo‐Lin Xiang
This map shows the geographic impact of Zuo‐Lin Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuo‐Lin Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuo‐Lin Xiang more than expected).
Fields of papers citing papers by Zuo‐Lin Xiang
This network shows the impact of papers produced by Zuo‐Lin Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuo‐Lin Xiang. The network helps show where Zuo‐Lin Xiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zuo‐Lin Xiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 107 | |
| 2 | 2009 | 87 | |
| 3 | 2019 | 58 | |
| 4 | 2011 | 43 | |
| 5 | 2011 | 42 | |
| 6 | 2009 | 39 | |
| 7 | 2016 | 28 | |
| 8 | 2013 | 23 | |
| 9 | 2010 | 23 | |
| 10 | 2011 | 22 | |
| 11 | 2015 | 18 | |
| 12 | 2012 | 17 | |
| 13 | 2011 | 13 | |
| 14 | [Nuclear accumulation of CXCR4 and overexpressions of VEGF-C and CK19 are associated with a higher risk of lymph node metastasis in hepatocellular carcinoma]. | 2010 | 11 |
| 15 | 2024 | 10 | |
| 16 | 2019 | 9 | |
| 17 | 2019 | 9 | |
| 18 | 2018 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2021 | 8 |
About Zuo‐Lin Xiang
Zuo‐Lin Xiang is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hepatology and Cancer Research, having authored 37 papers that have together received 633 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer-related molecular mechanisms research (5 papers), Lung Cancer Treatments and Mutations (5 papers), MicroRNA in disease regulation (4 papers), Ferroptosis and cancer prognosis (4 papers), Bone health and treatments (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Hepatology (156 citations), Cancer Research (241 citations), Oncology (227 citations), Immunology (91 citations) and Molecular Biology (285 citations). Zuo‐Lin Xiang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jia Fan, Zhao‐Chong Zeng, Zhao–You Tang, Haiying Zeng, Jian He, Yun-shan Tan, Dongmei Gao, Hui‐Chuan Sun, Peng–Yuan Zhuang and Ying Liang. Their work appears in journals such as Molecular Biology Reports, Oncotarget, BMC Bioinformatics, BMC Cancer and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.